LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
Position in COGT — Cogent Biosciences, Inc.
CIK 932974
BOSTON, MA
Position in COGT
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$77,400
+$420 QoQ
Shares Held
2,000
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#258
of 318 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $43,678,237 across 12 Biotechnology names. COGT ranks #5 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,875 | $41,075,697 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,317 | $1,647,653 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,533 | $461,478 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
500 | $268,475 | |
| 5 | COGT |
Cogent Biosciences, Inc.
This page
|
2,000 | $77,400 | |
| 6 | OCUL |
Ocular Therapeutix, Inc
|
7,500 | $73,650 | |
| 7 | MIRM |
Mirum Pharmaceuticals, Inc.
|
278 | $32,545 | |
| 8 | BNTX |
BioNTech SE
|
190 | $17,679 |
All Filings in COGT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,400 | 2,000 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $76,980 | 2,000 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $35,520 | 1,000 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $14,360 | 1,000 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $7,180 | 1,000 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $5,990 | 1,000 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $7,800 | 1,000 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $10,800 | 1,000 | Shares | Sole | 2024-10-25 | |
| No filing history on record for this holder in this stock. | ||||||